Introduction: Barcarena, located in the state of Pará, faces growing concerns regarding the impact of neoplasms on its population. Despite alarming perceptions of increasing cancer-related deaths, it is essential to conduct an analysis adjusted for population variations. This study uses data from DATASUS (2010–2022) to evaluate cancer mortality rates in Barcarena, comparing them to the state average and offering a more accurate perspective on the issue. Objectives: The main objectives of this study are to analyze cancer mortality rates in the municipality of Barcarena between 2010 and 2022 using official public health data, and to compare these rates with the state average of Pará, considering adjustments for population size and data categorized by place of hospitalization and residence. Methods: Secondary data were extracted from the DATASUS system via TABNET, covering the period from 2010 to 2022. Cancer mortality rates were calculated based on the number of deaths recorded by place of hospitalization and place of residence, adjusted for the local population, and expressed as deaths per 100,000 inhabitants. These data were compared to the state averages for Pará, enabling a comparative analysis across different regions. Results: Between 2010 and 2022, the cancer mortality rate in Barcarena by place of hospitalization was 0.51, ranking 69th out of 77 municipalities with available data. This rate is significantly lower than the state average of 8.64. By place of residence, Barcarena recorded a rate of 7.56, slightly below the state average. Although there is a stigma in the municipality regarding cancer incidence due to its industrial nature, the adjusted rates indicate that Barcarena’s mortality is below the state average. Conclusion: Cancer mortality rates in Barcarena are lower than the state average, both by place of hospitalization and residence, suggesting that despite population growth and reports of increasing deaths, the local situation is less severe than initially perceived. These findings are essential to guide public health policies aimed at cancer prevention and control in the municipality and surrounding region.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
